4
Changes in Ownership
INSMED Inc Filed Acc 0001628280-23-035712
Chair and CEO sold 112,000 shares at an average $24.08 ($2,696,449)
- Chair and CEO acquired 112,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lewis William · Chair and CEO
Table I: Non-derivative
13 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-10-27 | Exercise or conversion : show line 1 in the form 10b5-1 | +53,363 | $14.24 | $759,889 | 53,363 | I |
| 2023-10-27 | Sale : show line 2 in the form 10b5-1 | −53,363 | $24.04 | $1,282,847 | 0 | I |
| 2023-10-27 | Exercise or conversion : show line 3 in the form 10b5-1 | +1,322 | $14.24 | $18,825 | 1,322 | I |
| 2023-10-27 | Sale : show line 4 in the form 10b5-1 | −1,322 | $25.08 | $33,156 | 0 | I |
| 2023-10-27 | Exercise or conversion : show line 5 in the form 10b5-1 | +315 | $14.24 | $4,486 | 315 | I |
| 2023-10-27 | Sale : show line 6 in the form 10b5-1 | −315 | $26.00 | $8,190 | 0 | I |
| 2023-10-27 | Exercise or conversion : show line 7 in the form 10b5-1 | +500 | $14.24 | $7,120 | 500 | I |
| 2023-10-27 | Exercise or conversion : show line 8 in the form 10b5-1 | +55,350 | $14.24 | $788,184 | 289,274 | I |
| Open-market sales · 112,000 sh · avg $24.08 · $2,696,449 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-10-27 | Exercise or conversion : show line 14 in the form 10b5-1 Stock Option (right to buy) | −55,000 | $14.24 | 2023-10-31 | 55,000 | 500 | I |
| 2023-10-27 | Exercise or conversion : show line 15 in the form 10b5-1 Stock Option (right to buy) | −500 | $14.24 | 2023-10-31 | 500 | 0 | I |
| 2023-10-27 | Exercise or conversion : show line 16 in the form 10b5-1 Stock Option (right to buy) | −57,000 | $14.24 | 2023-10-31 | 57,000 | 0 | I |
Loading xslF345X05/wk-form4_1698782649.xml…